Go to the profile of F-star

F-star

 
  • + 44 (0)1223 497400
  • Partners
  • United Kingdom
Go to the profile of Maria Urban
Maria Urban

CEO, SEOFission

Go to the profile of Veronica Zacatenco
Veronica Zacatenco

Business Development Executive, Nature Publishing Group

Our team makes every effort to support the business development needs of the biopartnering community through our publications BioPharma Dealmakers, MedTech Dealmakers and our series of associated webcasts. I am interested in hearing about your partnering communication needs as well as your suggestions or comments.
Go to the profile of Albany A. Cordova Martins
Albany A. Cordova Martins

Business Development Executive, Nature Publishing Group, Springer Nature

Go to the profile of Kathrin Szimak
Kathrin Szimak

Business Development Manager Out-Licensing, OncoQR

Go to the profile of Freya Lowe
Freya Lowe

Community Manager, Dealslands.co.uk

Lowe Freya is working as a Community Manager at Dealslands.co.uk. In her leisure time, she really likes to share her views and her trips to various places.
Go to the profile of Carmen Ramirez
Carmen Ramirez

Sales Account Executive, Springer Nature

Go to the profile of Vandi Bharucha
Vandi Bharucha

Director, Thermo Fisher Scientific

Two research collaborations, one with the synthetic biochemistry team at GlaxoSmithKline (GSK) and the other with the Centre for Synthetic Biology and the department of bioengineering at Imperial College, London, have Sphere Fluidics working at the cutting edge of mass spectrometry (MS) and synthetic biology. MS is the technique of choice for characterizing proteins and chemicals and for distinguishing nuances between metabolite concentrations in biological samples. Following atom ionization, the masses of the molecules and their derivatives can be determined. However, compared to other technologies used to characterize biological samples such as genome sequencing, MS is a lowthroughput process. Sphere Fluidics’ picodroplet technology now provides a high-throughput approach for analyzing single cells or a few hundred picoliters of fluid containing the molecules of interest. The technology platform is already used to support a number of applications in the academic and biopharmaceutical research communities.
From the publishers of Nature, BioPharma Dealmakers brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. With a quarterly magazine that is distributed in Nature Biotechnology and Nature Reviews Drug Discovery, BioPharma Dealmakers provides insights into dealmaking trends and profiles from companies looking to partner – showcasing their pipeline products, technologies, therapeutic focus and partnering strategies.
Go to the profile of clifford pukel
clifford pukel

cancer vaccine cancer immunotherapy foundation

Go to the profile of Mohamed Ismail
Mohamed Ismail

Regulatory Affairs Specialist في Vitabiotics-Egypt, Vitabiotics-Egypt

Go to the profile of Kamal Yahoo!
Kamal Yahoo!

sales & marketing and HR manager at sedico, innovation corporation LTD

Go to the profile of Jenefer Thoroughgood
Jenefer Thoroughgood

Managing Director, Thoroughly Good Consulting

For nearly 20 years, I've worked in the digital media sector, with hands-on experience in editorial, marketing, sales and R&D. I'm passionate about engaging and understanding customers to develop great content and products. Formerly Chief Product & Customer Officer at Zapnito, I'm now an advisor to the company.
Go to the profile of Raveena Bhambra
Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Research

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 15 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.
Go to the profile of Claire Thompson
Claire Thompson

Global Manager, Business Development, Nature Publishing Group

I head up the business development team responsible for Nature's special partnering publications, BioPharma Dealmakers and MedTech Dealmakers, plus our series of associated webcasts. The team and I take a highly consultative approach to ensure that the individual business development needs of all the companies we with work, from the largest to the smallest, are effectively supported. I welcome the opportunity to hear from you, whether to investigate how our special partnering publications and tools might support your company, or to hear about your comments and suggestions.
Go to the profile of Jen Thoroughgood
Jen Thoroughgood

Former Head of Communities, Springer Nature

I'm no longer with Springer Nature so please send your community-related queries to communities@nature.com. Thanks!